X0HK3Q8
Insertion Sphenopalatine Ganglion to New Technology Group 8 with Neurostimulator Lead, Percutaneous Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | X New Technology |
| Body System | 0 Nervous System |
| Operation | H Insertion |
| Body Part | K Sphenopalatine Ganglion |
| Approach | 3 Percutaneous |
| Device | Q Neurostimulator Lead |
| Qualifier | 8 New Technology Group 8 |
Operation Definition
Putting in a nonbiological appliance that monitors, assists, performs, or prevents a physiological function but does not physically take the place of a body part
Procedure Overview
This family describes the placement of a nonbiological device into the nervous system that monitors, assists, performs, or prevents a physiological function, without replacing any body part outright. In practice, this typically involves implanting a new-technology device, such as a specialized neurostimulator or sensing system, designed to track neurological activity or intervene in real time to manage a condition like a movement disorder or seizure activity.
These devices are distinct from earlier-generation implants because they often incorporate closed-loop or responsive functionality, meaning they can sense abnormal neurological signals and respond automatically, rather than delivering a fixed, unchanging therapy. Placement is performed surgically, frequently with imaging guidance, and the device remains in the body on an ongoing basis to support the patient's neurological function over time.
Anatomy & Axis Detail
Sphenopalatine Ganglion
The sphenopalatine ganglion is a collection of autonomic nerve cells located behind the nasal cavity that plays a central role in trigeminal-autonomic headache disorders, including cluster headache and some forms of migraine, by relaying signals that produce the characteristic tearing, nasal congestion, and severe unilateral pain of an attack. Insertion of a neurostimulator device at this site allows patients to self-activate stimulation during an acute attack, interrupting the ganglion's signaling to abort or shorten the episode, and the device is implanted through a minimally invasive approach accessing the pterygopalatine fossa. Because the ganglion is deep and adjacent to the maxillary nerve and surrounding vasculature, precise placement is essential, and documentation should specify the device type and confirm the target as this specific autonomic ganglion rather than a nearby cranial nerve branch.
Approach: Percutaneous
In New Technology, Percutaneous describes entry into the body via needle or instrument puncture through the skin or a mucous membrane, without a surgical incision, mirroring the same concept in Medical and Surgical. It is distinguished from Open access, which requires a full incision, and from Percutaneous Endoscopic, which adds visualization through the puncture site.
Device / Substance / Technology: Neurostimulator Lead
Neurostimulator Lead specifies implantation or use of a lead device that delivers electrical stimulation to nervous system tissue as part of a novel neurostimulation therapy tracked under New Technology. It captures the lead component itself as the device used. It differs from Neurostimulator Lead with Paired Stimulation System, which indicates the lead is used together with an integrated stimulation system.
Qualifier: New Technology Group 8
Group 8 identifies technologies added to the New Technology section for the 2021-2022 update cycle, tying a given code to that specific approval year. The underlying substance, device, or technique is defined by the other six axis positions, not by the group number itself. Because group numbers simply track chronology, Group 8 differs from Group 7 and Group 9 only in when CMS granted the technology separate recognition.
Coding & Documentation
A coder needs documentation naming the specific approved device inserted, since New Technology codes correspond to particular technologies rather than a general class of implants, along with the anatomical location where the device or its leads were placed. The note should make clear the device was newly inserted rather than a component of an existing device being revised or replaced, and should describe its monitoring or responsive function. A common mistake is coding a routine neurostimulator implant under this family when it does not match the specific technology tied to the New Technology code, or confusing insertion of the device with insertion of just its leads or a related component, which may carry separate documentation requirements.
Commonly Confused With
This family is frequently confused with standard Insertion codes for neurostimulators found in the Medical and Surgical section, which cover comparable devices lacking the specific approved technology designation required for a New Technology code. It also overlaps conceptually with Replacement, which applies when a device is physically taking the place of a body part rather than simply monitoring or assisting function, and with Revision, which applies to correcting or adjusting a previously placed device rather than placing a new one.